当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Foteini Malli, Panagiotis Georgoulias, Varvara Valotassiou, Fotini Bardaka, Irene Tsilioni, Konstantinos I Gourgoulianis and Zoe Daniil*
Background: Studies in the literature suggest a regulatory role of leptin and adiponectin in the development of fibrosis in various organs. However, their role in idiopathic pulmonary fibrosis (IPF) has not been examined in the past. The study aimed to assess the levels of leptin and adiponectin in IPF patients and 22 controls. Methods: Leptin and adiponectin were measured in serum while leptin was assessed in broncholaveloar lavage fluid and exhaled breath condensate of IPF patients. The association of the adipokines levels with markers of disease severity was also addressed. Results: Leptin levels adjusted for BMI and leptin to adiponectin (L/A) ratio in male patients with PaO2 <65 were significantly reduced as compared to male patients with PaO2 ≥65 mmHg. L/A ratio was positively associated with PaO2. Additionally, L/A ratio were positively associated with Saint George Respiratory Questionnaire components. Interestingly, exhaled breath condensate and bronchoalveolar lavage fluid leptin were not associated with corresponding serum leptin levels. Discussion: Overall our findings suggest a possible role of leptin and adiponectin in the severity and/or pathogenesis of IPF. Further studies are required in order to clarify the mechanisms and physiological relevance of our observations.